| Fosinopril Metabolism Pathway |  | Drug Metabolism | Fosinopril / Zinc |
| Fosphenytoin (Antiarrhythmic) Action Pathway |  | Drug Action | ATP / Phenytoin / Fosphenytoin / Potassium cation / Calcium |
| Fosphenytoin (Antiarrhythmic) Metabolism Pathway |  | Drug Metabolism | Phenytoin / Fosphenytoin |
| Fosphenytoin Action Pathway (New) |  | Drug Action | Phenytoin / Fosphenytoin / Potassium cation / Calcium / Mesoheme |
| Fosphenytoin Predicted Metabolism Pathway |  | Metabolic | Fosphenytoin / Mesoheme |
| Fospropofol Action Pathway |  | Drug Action | Pyridoxal phosphate / Glutamic acid / ATP / Calcium / Magnesium cation / Cyclic adenosine monophosphate / gamma-Aminobutyric acid / Pyrophosphoric acid / Fospropofol |
| Fospropofol Predicted Metabolism Pathway |  | Metabolic | Mesoheme / Fospropofol |
| Fostamatinib Predicted Metabolism Pathway |  | Metabolic | Mesoheme / Fostamatinib |
| Fostemsavir Action Pathway |  | Drug Action | Calcium / Magnesium cation / Zinc / Fostemsavir |
| Frovatriptan Mechanism of Action Action Pathway |  | Drug Action | ATP / Frovatriptan / Calcium / Magnesium cation / Cyclic adenosine monophosphate / Pyrophosphoric acid |
| Fructose and Mannose Degradation |  | Metabolic | NADH / ATP / Magnesium cation / Zinc / Sorbitol / D-glyceraldehyde 3-phosphate / D-Mannose 1-phosphate / beta-L-fucose / Pyrophosphoric acid / Fructose / Dihydroxyacetone phosphate |
| Fructose Intolerance, Hereditary |  | Disease | NADH / ATP / Magnesium cation / Zinc / Sorbitol / D-glyceraldehyde 3-phosphate / D-Mannose 1-phosphate / beta-L-fucose / Pyrophosphoric acid / Fructose / Dihydroxyacetone phosphate |
| Fructose Intolerance, Hereditary |  | Disease | NADH / ATP / Magnesium cation / Zinc / Sorbitol / D-glyceraldehyde 3-phosphate / D-Mannose 1-phosphate / beta-L-fucose / Pyrophosphoric acid / Fructose / Dihydroxyacetone phosphate |
| Fructose-1,6-diphosphatase Deficiency |  | Disease | Pyruvic acid / Biotin / NADH / ATP / Magnesium cation / 2-phospho-D-glyceric acid / Phosphoenolpyruvate / D-glyceraldehyde 3-phosphate / Oxogluric acid / Dihydroxyacetone phosphate |
| Fructose-1,6-diphosphatase Deficiency |  | Disease | Pyruvic acid / Biotin / NADH / ATP / Magnesium cation / 2-phospho-D-glyceric acid / Phosphoenolpyruvate / D-glyceraldehyde 3-phosphate / Oxogluric acid / Dihydroxyacetone phosphate |
| Fructosuria |  | Disease | NADH / ATP / Magnesium cation / Zinc / Sorbitol / D-glyceraldehyde 3-phosphate / D-Mannose 1-phosphate / beta-L-fucose / Pyrophosphoric acid / Fructose / Dihydroxyacetone phosphate |
| Fructosuria |  | Disease | NADH / ATP / Magnesium cation / Zinc / Sorbitol / D-glyceraldehyde 3-phosphate / D-Mannose 1-phosphate / beta-L-fucose / Pyrophosphoric acid / Fructose / Dihydroxyacetone phosphate |
| Fumarase Deficiency |  | Disease | Pyruvic acid / Biotin / Succinic acid / NADH / ATP / Magnesium cation / Oxogluric acid / Flavin adenine dinucleotide / Citric acid / Maleic acid |
| Fumarase Deficiency |  | Disease | Pyruvic acid / Biotin / Succinic acid / NADH / ATP / Magnesium cation / Oxogluric acid / Flavin adenine dinucleotide / Citric acid / Maleic acid |
| Furosemide Action Pathway |  | Drug Action | Cysteine / Furosemide / Potassium cation / Urea |
| Furosemide Diuretic Action Pathway |  | Drug Action | Furosemide / Potassium cation |
| Furosemide Predicted Metabolism Pathway |  | Metabolic | Furosemide / Mesoheme |
| Fusafungine Predicted Metabolism Pathway |  | Metabolic | Mesoheme / Fusafungine |
| Futibatinib Drug Metabolism |  | Metabolic | Futibatinib |
| G(M2)-Gangliosidosis: Variant B, Tay-Sachs Disease |  | Disease | Uridine-5'-Diphosphate |